Objectives: To develop risk predictive models of postpartum stress urinary incontinence (SUI) for both primiparous and multiparous women. Materials and Methods: From July 2016 to July 2017, 815 singleton pregnant women without incontinence before pregnancy who were 18 years or older and admitted to 2 hospitals in Shenzhen, China, were enrolled. Pregnancy-related data were collected at enrollment. Delivery information was obtained from electronic medical records. Telephone follow-up was conducted to investigate SUI at 6 weeks postpartum. Multivariable logistic regression analyses using stepwise selection were used to establish predictive models for postpartum SUI for all women, and separately for primiparous and multiparous. Internal validation of the models was performed with discrimination and calibration using a bootstrapping (1,000 resampling) method. Results: The analysis included 727 participants. The prevalence of postpartum SUI was 15.96% (116/727), 12.5% (49/393) for primiparous women and 20.1% (67/334) for multiparous women, with a significant difference between them (p = 0.008). For primiparous women, the predictive postpartum SUI model included age, abortion/miscarriage history, SUI during pregnancy, and mode of delivery. For multiparous women, pre-pregnancy BMI, abortion/miscarriage history, SUI during pregnancy, and mode of delivery were included in the model. There was satisfactory calibration between the models’ predicted probability of postpartum SUI and the observed probability for both primiparous and multiparous women (Hosmer-Lemeshow test, p = 0.390 for primiparous and 0.364 for multiparous women). The optimism-corrected C-statistic of the models by bootstrapping stepwise was 0.763 (95% confidence interval [CI]: 0.693–0.833) for primiparous women and 0.783 (95% CI: 0.726–0.841) for multiparous women. Conclusion: We developed predictive models of postpartum SUI for both primiparous and multiparous women. This approach may provide a useful tool for high-risk prediction of postpartum SUI before and after delivery.

1.
Haylen
BT
,
de Ridder
D
,
Freeman
RM
,
Swift
SE
,
Berghmans
B
,
Lee
J
, et al.
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction
.
Neurourol Urodyn
.
2010 Jan
;
29
(
1
):
4
20
.
2.
Liang
CC
,
Chang
SD
,
Lin
SJ
,
Lin
YJ
.
Lower urinary tract symptoms in primiparous women before and during pregnancy
.
Arch Gynecol Obstet
.
2012 May
;
285
(
5
):
1205
10
.
3.
Zhu
L
,
Li
L
,
Lang
JH
,
Xu
T
.
Prevalence and risk factors for peri- and postpartum urinary incontinence in primiparous women in China: a prospective longitudinal study
.
Int Urogynecol J
.
2012 May
;
23
(
5
):
563
72
.
4.
Oliveira
C
,
Seleme
M
,
Cansi
PF
,
Consentino
RF
,
Kumakura
FY
,
Moreira
GA
, et al.
Urinary incontinence in pregnant women and its relation with socio-demographic variables and quality of life
.
Rev Assoc Med Bras
.
2013 Sep
;
59
(
5
):
460
6
.
5.
Siracusano
S
,
Pregazzi
R
,
d'Aloia
G
,
Sartore
A
,
Di Benedetto
P
,
Pecorari
V
, et al.
Prevalence of urinary incontinence in young and middle-aged women in an Italian urban area
.
Eur J Obstet Gynecol Reprod Biol
.
2003 Apr
;
107
(
2
):
201
4
.
6.
Viktrup
L
,
Rortveit
G
,
Lose
G
.
Risk of stress urinary incontinence twelve years after the first pregnancy and delivery
.
Obstet Gynecol
.
2006 Aug
;
108
(
2
):
248
54
.
7.
Boyle
R
,
Hay-Smith
EJ
,
Cody
JD
,
Mørkved
S
,
Hay-Smith
E
.
Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women
.
Cochrane Database Syst Rev
.
2017 Dec
;
10
:
CD007471
.
8.
Fritel
X
,
de Tayrac
R
,
Bader
G
,
Savary
D
,
Gueye
A
,
Deffieux
X
, et al.
Preventing urinary incontinence with supervised prenatal pelvic floor exercises: a randomized controlled trial
.
Obstet Gynecol
.
2015 Aug
;
126
(
2
):
370
7
.
9.
Jelovsek
JE
,
Piccorelli
A
,
Barber
MD
,
Tunitsky-Bitton
E
,
Kattan
MW
.
Prediction models for postpartum urinary and fecal incontinence in primiparous women
.
Female Pelvic Med Reconstr Surg
.
2013 Mar-Apr
;
19
(
2
):
110
8
.
10.
Rortveit
G
,
Hannestad
YS
,
Daltveit
AK
,
Hunskaar
S
.
Age- and type-dependent effects of parity on urinary incontinence: the Norwegian EPINCONT study
.
Obstet Gynecol
.
2001 Dec
;
98
(
6
):
1004
10
.
11.
K
,
Fleten
C
,
Nystad
W
.
Effect of antenatal pelvic floor muscle training on labor and birth
.
Obstet Gynecol
.
2009 Jun
;
113
(
6
):
1279
84
.
12.
Chan
SS
,
Cheung
RY
,
Yiu
KW
,
Lee
LL
,
Chung
TK
.
Prevalence of urinary and fecal incontinence in Chinese women during and after their first pregnancy
.
Int Urogynecol J
.
2013 Sep
;
24
(
9
):
1473
9
.
13.
Pregazzi
R
,
Sartore
A
,
Troiano
L
,
Grimaldi
E
,
Bortoli
P
,
Siracusano
S
, et al.
Postpartum urinary symptoms: prevalence and risk factors
.
Eur J Obstet Gynecol Reprod Biol
.
2002 Jul 10
;
103
(
2
):
179
82
.
14.
Dietz
HP
,
Eldridge
A
,
Grace
M
,
Clarke
B
.
Does pregnancy affect pelvic organ mobility?
Aust N Z J Obstet Gynaecol
.
2004 Dec
;
44
(
6
):
517
20
.
15.
Shek
KL
,
Dietz
HP
.
Intrapartum risk factors for levator trauma
.
BJOG
.
2010
;
117
(
12
):
1485
92
.
16.
Glazener
CM
,
Herbison
GP
,
MacArthur
C
,
Lancashire
R
,
McGee
MA
,
Grant
AM
, et al.
New postnatal urinary incontinence: obstetric and other risk factors in primiparae
.
BJOG
.
2006 Feb
;
113
(
2
):
208
17
.
17.
Wilson
PD
,
Herbison
RM
,
Herbison
GP
.
Obstetric practice and the prevalence of urinary incontinence three months after delivery
.
Br J Obstet Gynaecol
.
1996 Feb
;
103
(
2
):
154
61
.
18.
Zincir
H
,
Demir
G
,
Günaydin
Y
,
Ozen
B
.
Sexual dysfunction in married women with urinary incontinence
.
Urol J
.
2018 Jul 10
;
15
(
4
):
193
8
.
19.
Hosmer
DW
,
Lemeshow
S
,
Sturdivant
RX
.
Applied logistic regression
. 3rd ed.
Hoboken, NY
:
Wiley
;
2013
.
20.
Grobman
WA
,
Lai
Y
,
Landon
MB
,
Spong
CY
,
Leveno
KJ
,
Rouse
DJ
, et al.
Development of a nomogram for prediction of vaginal birth after cesarean delivery
.
Obstet Gynecol
.
2007 Apr
;
109
(
4
):
806
12
.
21.
Foldspang
A
,
Mommsen
S
,
Djurhuus
JC
.
Prevalent urinary incontinence as a correlate of pregnancy, vaginal childbirth, and obstetric techniques
.
Am J Public Health
.
1999 May
;
89
(
2
):
209
12
.
22.
Rortveit
G
,
Daltveit
AK
,
Hannestad
YS
,
Hunskaar
S
.
Urinary incontinence after vaginal delivery or cesarean section
.
N Engl J Med
.
2003 Mar
;
348
(
10
):
900
7
.
23.
Nygaard
I
.
Should women be offered elective cesarean section in the hope of preserving pelvic floor function?
Int Urogynecol J Pelvic Floor Dysfunct
.
2005 Jun
;
16
(
4
):
255
6
.
24.
Milsom
I
.
Can we predict and prevent pelvic floor dysfunction?
Int Urogynecol J
.
2015 Dec
;
26
(
12
):
1719
23
.
25.
Kokabi
R
,
Yazdanpanah
D
.
Effects of delivery mode and sociodemographic factors on postpartum stress urinary incontinency in primipara women: a prospective cohort study
.
J Chin Med Assoc
.
2017 Aug
;
80
(
8
):
498
502
.
26.
King
JK
,
Freeman
RM
.
Is antenatal bladder neck mobility a risk factor for postpartum stress incontinence?
Br J Obstet Gynaecol
.
1998 Dec
;
105
(
12
):
1300
7
.
27.
Pizzoferrato
AC
,
Fauconnier
A
,
Bader
G
,
de Tayrac
R
,
Fort
J
,
Fritel
X
.
Is prenatal urethral descent a risk factor for urinary incontinence during pregnancy and the postpartum period?
Int Urogynecol J
.
2016 Jul
;
27
(
7
):
1003
11
.
28.
Thom
DH
,
Rortveit
G
.
Prevalence of postpartum urinary incontinence: a systematic review
.
Acta Obstet Gynecol Scand
.
2010 Dec
;
89
(
12
):
1511
22
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.